Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Recurrence 1Carcinoma, Small Cell 1

Interventions

Topotecan 3pembrolizumab 2Gemcitabine 2vinflunine 1bemiparin 1belotecan 1apalutamide 1Temozolomide 1Taxes 1Sorafenib 1Penfluridol 1Pemetrexed 1Paclitaxel 1Nortriptyline 1Nivolumab 1Ipilimumab 1Etoposide 1Docetaxel 1Cisplatin 1Carboplatin 1Arsenic Trioxide 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Small Cell × Penfluridol × Clear all
NCT07206563 2025-10-03

Penfluridol for Relapsed/Refractory Small Cell Cancers

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 1/2 Not yet recruiting
33 enrolled
Thoracic

Recurrence, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡